Based on the Inspire Medical Systems Inc stock forecast from 10 analysts, the average analyst target price for Inspire Medical Systems Inc is USD 236.33 over the next 12 months. Inspire Medical Systems Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Inspire Medical Systems Inc is Neutral, which is based on 5 positive signals and 6 negative signals. At the last closing, Inspire Medical Systems Inc’s stock price was USD 186.29. Inspire Medical Systems Inc’s stock price has changed by -0.36% over the past week, -6.54% over the past month and -4.67% over the last year.
No recent analyst target price found for Inspire Medical Systems Inc
No recent average analyst rating found for Inspire Medical Systems Inc
Company Overview Inspire Medical Systems Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota. Read Less
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimul...Read More
Frequently Asked Questions About Inspire Medical Systems Inc (INSP) Stock
Based on ratings from 10 analysts Inspire Medical Systems Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 13 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on INSP's stock to indicate if its a good dividend stock.
Based on targets from 10 analysts, the average taret price for INSP is USD 236.33 over the next 12 months. The maximum analyst target price is USD 270 while the minimum anlayst target price is USD 197.
INSP stock's Price/Earning ratio is 169.16.
Our analysis grades INSP stock's Price / Earning ratio at F. This means that INSP stock's Price/Earning ratio is above 80% of the stocks in the Medical Devices sector in the NYE exchange.
Based on this INSP may be a overvalued for its sector.
The last closing price of INSP's stock was USD 186.29.
The most recent market capitalization for INSP is USD 5.63B.
Based on targets from 10 analysts, the average taret price for INSP is projected at USD 236.33 over the next 12 months.
This means that INSP's stock price may go up by +26.86% over the next 12 months.
We can't find any ETFs which contains Inspire Medical Systems Inc's stock.
As per our most recent records Inspire Medical Systems Inc has 1,011 Employees.
Inspire Medical Systems Inc's registered address is 5500 Wayzata Blvd., Golden Valley, MN, United States, 55416.
You can get more information about it from Inspire Medical Systems Inc's website at https://www.inspiresleep.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Inspire Medical Systems Inc (INSP) Stock
Based on ratings from 10 analysts Inspire Medical Systems Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 13 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on INSP's stock to indicate if its a good dividend stock.
Based on targets from 10 analysts, the average taret price for INSP is USD 236.33 over the next 12 months. The maximum analyst target price is USD 270 while the minimum anlayst target price is USD 197.
INSP stock's Price/Earning ratio is 169.16.
Our analysis grades INSP stock's Price / Earning ratio at F. This means that INSP stock's Price/Earning ratio is above 80% of the stocks in the Medical Devices sector in the NYE exchange.
Based on this INSP may be a overvalued for its sector.
The last closing price of INSP's stock was USD 186.29.
The most recent market capitalization for INSP is USD 5.63B.
Based on targets from 10 analysts, the average taret price for INSP is projected at USD 236.33 over the next 12 months.
This means that INSP's stock price may go up by +26.86% over the next 12 months.
We can't find any ETFs which contains Inspire Medical Systems Inc's stock.
As per our most recent records Inspire Medical Systems Inc has 1,011 Employees.
Inspire Medical Systems Inc's registered address is 5500 Wayzata Blvd., Golden Valley, MN, United States, 55416.
You can get more information about it from Inspire Medical Systems Inc's website at https://www.inspiresleep.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for INSP !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
